Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vibrant Capsule for Chronic Idiopathic Constipation
NCT04458675Phase 4Completed
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial (2 arms). Primary endpoints: CSBM1 Success Rate at 8 weeks and CSBM2 Success Rate at 8 weeks. Started Jul 2018; status: completed.
Beyond the preview
Go deeper on NCT04458675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04458675.